13 terminated. 13 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 13 | Terminated 13 |
| Phase 3 | 1 | Terminated 1 |
Follow Peritoneal Neoplasms: new trials by email Literature Review of Peritoneal Neoplasms trials Research Report on Peritoneal Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Near-infrared Imaging With Indocyanine Green for Detection of Peritoneal Metastases for Gastric Adenocarcinoma. Indocyanine green - Gastric Cancer, Gastric Adenocarcinoma | Phase 2 | Terminated | Laval University | 11 | 2022-12-15 | 2024-04-02 |
| Pasireotide to Reduce Clinically Relevant Digestive Leakage After Complete Cytoreductive Surgery (CRS) Plus Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) for Peritoneal Carcinomatosis Pasireotide 0.9 MG/ML, Saline water - Peritoneal Carcinomatosis | Phase 2 | Terminated | Gustave Roussy, Cancer Campus, Grand Paris | 6 | 2020-09-03 | 2024-02-08 |
| Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis Paclitaxel, Capecitabine, BardPort Titanium Implanted Port with Peritoneal Catheter - Gastric Adenocarcinoma, Gastric Cancer | Phase 2 | Terminated | National Cancer Institute (NCI) | 12 | 2020-06-09 | 2026-05-05 |
| Phase 2 RCT of Alvimopan vs. Placebo After CRS/HIPEC Alvimopan, Placebo - Ileus | Phase 2 | Terminated | University of California, San Diego | 84 | 2018-03-08 | 2021-08-18 |
| Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stomach CAncer: a Feasibility Study Perioperative chemotherapy, Cytoreduction, HIPEC - Gastric Cancer, Peritoneal Carcinomatosis | Phase 2 | Terminated | Richard van Hillegersberg | 3 | 2017-08-01 | 2019-04-17 |
| Randomized Controlled Trial to Prevent Peritoneal Seeding in Gastric Cancer positive cytology with HIPEC - Gastric Cancer, Peritoneal Carcinomatosis | Phase 2 / Phase 3 | Terminated | University Hospital Tuebingen | 3 | 2012-09-01 | 2018-01-30 |
| Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer Birinapant (TL32711) - Epithelial Ovarian Cancer, Peritoneal Neoplasms | Phase 2 | Terminated | National Cancer Institute (NCI) | 11 | 2012-08-15 | 2017-05-30 |
| Combined Anticancer Treatment of Advanced Colon Cancer CRS, HIPEC - Peritoneal Carcinomatosis, Colorectal Cancer Metastatic | Phase 2 | Terminated | University of Regensburg | 26 | 2010-10-01 | 2018-09-05 |
| Cytoreductive Surgery(CRS) Plus Hyperthermic Intraoperative Peritoneal Chemotherapy(HIPC) With Cisplatin to Treat Peritoneal Carcinomatosis From Upper Gastrointestinal Cancer Cytoreductive Surgery (CRS) plus Hyperthermic Intraoperative Peritoneal Chemotherapy with Cisplatin (HIPC) - Peritoneal Carcinomatosis, Gastrointestinal Cancer | Phase 2 | Terminated | Baki Topal | 34 | 2010-07-01 | 2015-12-02 |
| A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer Volociximab - Ovarian Cancer, Peritoneal Neoplasms | Phase 2 | Terminated | Facet Biotech | 16 | 2007-08-01 | 2012-08-23 |
| Chemotherapy and Cetuximab in Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer cetuximab, fluorouracil, leucovorin calcium - Colorectal Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | Terminated | Institut BergoniƩ | 18 | 2007-05-01 | 2025-08-29 |
| Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Vandetanib - Ovarian Neoplasms, Fallopian Tube Neoplasms | Phase 2 | Terminated | National Cancer Institute (NCI) | 12 | 2007-01-01 | 2012-06-26 |
| A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis Surgical debulking with peritonectomy, Intraperitoneal 5FU, FOLFOX - Peritoneal Neoplasms | Phase 2 | Terminated | Washington University School of Medicine | 18 | 2006-05-01 | 2016-12-13 |
Stomach Neoplasms (4) · Carcinoma, Ovarian Epithelial (2) · Colorectal Neoplasms (2) · Fallopian Tube Neoplasms (2) · Ovarian Neoplasms (2) · Adenocarcinoma (1) · Colonic Neoplasms (1) · Gastrointestinal Neoplasms (1) · Ileus (1) · Neoplasms (1) · Rectal Neoplasms (1)
Abdominal Neoplasms (13) · Digestive System Diseases (13) · Digestive System Neoplasms (13) · Neoplasms by Site (13) · Peritoneal Diseases (13) · Neoplasms (12) · Gastrointestinal Diseases (8) · Gastrointestinal Neoplasms (6) · Stomach Diseases (4) · Adnexal Diseases (3) · Carcinoma (3) · Endocrine Gland Neoplasms (3) · Endocrine System Diseases (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3)
Cytoreduction Surgical Procedures (3) · Hyperthermic Intraperitoneal Chemotherapy (3) · Cisplatin (2) · Fluorouracil (2) · Leucovorin (2) · Oxaliplatin (2) · Capecitabine (1) · Cetuximab (1) · Chemotherapy, Adjuvant (1) · Folfox protocol (1) · Indocyanine Green (1) · Paclitaxel (1) · Saline Waters (1) · alvimopan (1) · birinapant (1)
National Cancer Institute (NCI) (3) · Baki Topal (1) · Facet Biotech (1) · Gustave Roussy, Cancer Campus, Grand Paris (1) · Institut BergoniĆ© (1) · Laval University (1) · Richard van Hillegersberg (1) · University Hospital Tuebingen (1) · University of California, San Diego (1) · University of Regensburg (1) · Washington University School of Medicine (1)
United States (6) · Canada (2) · France (2) · Germany (2) · Belgium (1) · Netherlands (1)
Alexandre Brind'Amour, MD (1) · Andrew Blakely, M.D. (1) · Baki Topal, MD, PhD (1) · C. William Helm, MD (1) · Carolyn Matthews, MD (1) · Christina M Annunziata, M.D. (1) · Dana Glenn, MD (1) · Deborah Armstrong, MD (1) · Elise C Kohn, M.D. (1) · Eric Winquist, MD (1) · Ernst Lengyel, MD (1) · James Burke, MD (1) · James Fleshman, M.D. (1) · Jelle P Ruurda, MD PhD (1)
PMID 20068097, PMID 27520560, PMID 29149865, PMID 30131226, PMID 31331370, PMID 36102565
2009 (1), 2016 (1), 2019 (1)